Imagen 1 de 1
Foto genérica
Imagen 1 de 1
Foto genérica
Evidence-Biased Antidepressant Prescription : Overmedicalisation, Flawed Research, and Conflicts of Interest by Michael P. Hengartner (2021, Hardcover)
AlibrisBooks (464263)
98,6% de votos positivos
Precio:
USD161,95
Aproximadamente139,11 EUR
+ USD22,79 de envío
Devoluciones:
30 días para devoluciones. El comprador paga el envío de la devolución..
Estado:
New Hard cover
- ¡Cómpralo ya!Evidence-Biased Antidepressant Prescription: Overmedicalisation, Flawed Research
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Acerca de este artículo
Product Identifiers
PublisherSpringer International Publishing A&G
ISBN-103030825868
ISBN-139783030825867
eBay Product ID (ePID)26050415170
Product Key Features
Number of PagesVII, 354 Pages
LanguageEnglish
Publication NameEvidence-Biased Antidepressant Prescription : Overmedicalisation, Flawed Research, and Conflicts of Interest
Publication Year2021
SubjectClinical Medicine, Clinical Psychology, Psychiatry / General, Disease & Health Issues
TypeTextbook
AuthorMichael P. Hengartner
Subject AreaSocial Science, Psychology, Medical
FormatHardcover
Dimensions
Item Weight22.2 Oz
Item Length8.3 in
Item Width5.8 in
Additional Product Features
Dewey Edition23
Number of Volumes1 vol.
IllustratedYes
Dewey Decimal616.8527061
Table Of Content1. Introduction: How did I get here? 2. Antidepressants in clinical practice 3. Medico-cultural contexta. Evidence-based medicineb. Medicalisation and pharmaceuticalisation4. Flaws in antidepressant researcha. Selective reporting and spinb. Methodological bias5. Conflicts of interest in psychiatrya. Denial and minimization of harmb. Corporate bias6. Solutions for reform
Synopsis1. Introduction: How did I get here? 2. Antidepressants in clinical practice 3. Medico-cultural context a. Evidence-based medicine b. Medicalisation and pharmaceuticalisation 4. Flaws in antidepressant research a. Selective reporting and spin b. Methodological bias 5. Conflicts of interest in psychiatry a. Denial and minimization of harm b. Corporate bias 6. Solutions for reform, This book addresses the over-prescribing of antidepressants in people with mostly mild and subthreshold depression. It outlines the steep increase in antidepressant prescription and critically examines the current scientific evidence on the efficacy and safety of antidepressants in depression. The book is not only concerned with the conflicting views as to whether antidepressants are useful or ineffective in various forms of depression, but also aims at detailing how flaws in the conduct and reporting of antidepressant trials have led to an overestimation of benefits and underestimation of harms. The transformation of the diagnostic concept of depression from a rare but serious disorder to an over-inclusive, highly prevalent but predominantly mild and self-limiting disorder is central to the books argument. It maintains that biological reductionism in psychiatry and pharmaceutical marketing reframed depression as a brain disorder, corroborating the overemphasis on drug treatment in both research and practice. Finally, the author goes on to explore how pharmaceutical companies have distorted the scientific literature on the efficacy and safety of antidepressants and how patient advocacy groups, leading academics, and medical organisations with pervasive financial ties to the industry helped to promote systematically biased benefit-harm evaluations, affecting public attitudes towards antidepressants as well as medical education, training, and practice.
LC Classification NumberRC466.8-467.97
